BALB/cHeA (BALB/c) mice are sensitive to radiation lymphomagenesis, while STS/A (STS) mice are resistant. We have selected a recombinant mouse, R1, with a STS-derived D16Mit165-D16Mit34 segment in the vicinity of the centromere of chromosome 16 among progeny from a (CcS-7/Dem × BALB/c)F 1 x BALB/c backcross. To test the susceptibility to radiation lymphomagenesis, we generated a genetic cross by mating the male and female R1 progeny obtained by 4-6 backcrosses of R1 to BALB/ c. The mice were subjected to 4 × 1.7 Gy of X-irradiation. Of 120 mice analyzed, 94 developed lymphomas (91, of thymic type; 3, of nonthymic type) within 315 days of observation. The analysis indicated a link between the susceptibility to lymphomagenesis and the marker D16Mit34 on chromosome 16. The mice heterozygous for the BALB/c and STS alleles at D16Mit34 were less sensitive to lymphomagenesis than the mice homozygous at this locus. There was no significant difference in latency among the genotypes. Our study showed the existence of a susceptibility locus for radiation lymphomagenesis on chromosome 16 and revealed aspects of the genetics of lymphoma susceptibility.
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Fractionated whole-body X-irradiation is a well-established procedure that can efficiently induce lymphomas in susceptible strains of mice 1) . These lymphomas are mostly T-cell lymphomas of thymic origin 2, 3) . Among various strains of mice, a few including STS/A (STS) and MSM/Ms have been reported to be resistant to radiation lymphomagenesis, as compared with susceptible strains, such as BALB/cHeA (BALB/c) 4, 5) . To analyze the genetic control of lymphoma susceptibility, recombinant strains whose parental strains are BALB/c and STS were used. An analysis of the strain distribution pattern of the recombinant inbred CXS strains containing 50% of the STS and BALB/c genome each suggested the presence of a potential lymphoma susceptibility locus on chromosome 4 6) . A study using the recombinant congenic CcS/ Dem series, which contains approximately 12.5% of the STS genome in the BALB/c back- ground, a genetic tool designed for the analysis of complex and multigenic traits, established and maintained at The Netherlands Cancer Institute in Amsterdam 7) , showed a suggestive linkage controlling the latency of lymphomagenesis on chromosome 5 8) . Despite these extensive studies, the genetic control of susceptibility to radiation lymphomagenesis is not well understood, conceivably because multiple genes are involved. To analyze potentially multigenic traits, such as tumor susceptibility, congenic strains with a chromosomal segment derived from one of the resistant or sensitive strains in a different genetic background might be useful.
To test the possibility outlined above, we are presently preparing congenic strains each of which contains a small portion of STS-derived chromosomes in the BALB/c background. Among the mice with recombination on chromosome 16, which were originally selected among (CcS-7/Dem × BALB/c)F 1 × BALB/c backcrossed mice, was a mouse named R1 with a STS-derived D16Mit165 -D16Mit34 segment near to the centromere of chromosome 16. Because the centromeric region of chromosome 16 has been implicated in radiation-induced apoptosis 9) and tumorigenesis, as indicated by a loss of heterozygosity 10) , it is of interest to test the susceptibility to radiation lymphomagenesis using the R1 progeny.
To test linkage we produced a genetic cross by mating female and male R1 progeny obtained by 4-6 backcrosses of R1 to BALB/c. The genetic composition of chromosome 16 for the R1 progeny of this generation is depicted in Fig. 1 In our study, only female mice were subjected to fractionated (4 × 1.7 Gy) X-irradiation at weekly intervals, starting at 4-5 weeks of age, to exclude the well-documented sex difference in radiation lymphomagenesis 11) . An observation of lymphomagenesis was performed every other day on weekdays for 315 days after the final irradiation. When the mice appeared to be moribund, they were killed and autopsied, in order to examine the generation of lymphoma, and involved tissues were processed for histology. Genotypes for these mice were examined by PCR amplification of DNA isolated from mouse tails through a conventional protainase K digestion procedure with primers unique for the microsatellite marker D16Mit34, purchased from Research Genetics Inc. (Hantsville, AL). The PCR program consisted of one cycle at 94°C for 3 min, 30 cycles at 94°C for 30 sec, 55°C for 1 min and 72°C for1 min. The PCR products were analyzed on a 8% acrylamide gel, and genotypes were determined by analyzing DNA bands visualized by ethidium bromide staining. Of 121 mice exposed to X-irradiation, one mouse developed mammalian adenocarcinoma. This case was excluded from the subsequent analysis. Of the remaining 120 mice, 94 developed lymphomas within 315 days of observation. These lymphomas started to arise 3-4 months after the final irradiation, and then a steep rise in the cumulative incidence of lymphomas at 5 -7 months was followed by a quiescent phase. In 91 cases, the lymphomas were of thymic origin; they arose in the thymus and proliferated in situ. These thymic lymphomas were frequently accompanied by an enlargement of the spleen, as determined by an autopsy, and infrequently involved multiple organs, such as the spleen, liver, kidney, and mesenteric and peripheral lymph nodes. Because the remaining 3 lymphomas were nonthymic, there was no enlargement of the thymus. The pattern of generation and the pathological features of lymphomas in our experiment were largely consistent with previous findings 2, 5, 6) . The final incidence of lymphomas and the average latent period for the mice sorted by the D16Mit34 genotype are represented in Table 1 . In the mice homozygous for the BALB/c, heterozygous for the BALB/c and STS, and homozygous for the STS allele at D16Mit34, incidences of lymphomas were 91% (21/23), 69% (47/68) and 90% (26/29), respectively. No significant difference was observed in the latent period among the genotypes. We then analyzed the survival by the Kaplan-Meier method. A comparison of the survival for those mice sorted by the D16Mit34 genotype using the Log-Rank test showed a significant difference (χ 2 = 10.64, degrees of freedom = 2, P <0.005). The survival curve for the mice heterozygous for the BALB/ c and STS alleles at the marker D16Mit34 is represented in Fig2 along with that for the mice with homozygous BALB/c alleles ( Fig. 2a) and that for the mice with homozygous STS alleles (Fig. 2b) . As indicated in the graphs, those mice carrying one STS allele at D16Mit34 in the BALB/c background were less sensitive to radiation lymphomagenesis than the mice homozygous for either the BALB/c or STS allele at this locus.
In the present study, we detected a link between the susceptibility to radiation lymphomagenesis and D16Mit34 in the proximal region of chromosome 16. Although the mice heterozygous for the BALB/c and STS alleles at D16Mit34 were relatively resistant to lymphomagenesis compared with the mice homozygous for the BALB/c alleles at this marker, the survival curve for the STS homozygotes appeared not to be different from that for the BALB/c homozygotes. These controversial results indicate that the higher survivorship for the heterozygotes may not be due to the STS allele at the susceptibility locus on chromosome 16, but to ancestral STS alleles somewhere on other chromosomes. To test this possibility, we genotyped the parents with primers unique to markers D1Mit43, D3Mit1, D5Mit179, D6Mit48, D7Nds5, D8Mit80, D11Mit51, D12Mit12, D15Mit108, D17Mit3 and D19Mit10, where the CcS-7/Dem mice carry the STS alleles 12) . Because some of these mice retained the STS allele at the markers D11Mit51 and/or D7Nds5, we also genotyped the cross with these markers. The survival for the mice sorted by the D11Mit51 genotype was 24% (18/75) for the BALB/c homozygotes, 20% (8/40) for the BALB/c and STS heterozygotes and 0% (0/5) for the STS homozygotes; the survival for the mice sorted by the D7Nds5 genotype was18% (19/ 103) for the BALB/c homozygotes and 41% (7/17) for the BALB/c and STS heterozygotes. No significant linkage was detected to any of these markers (D11Mit51, P>0.8; D7Nds5, P=0.128). Moreover, excluding those mice with the STS allele at either of these markers from the analysis conferred no substantial change to the survivals for the mice sorted by the D16Mit34 genotype, hence ruling out the above possibility. Alternatively, the decreased survival for the STS homozygotes as compared with the heterozygotes may be explained by the presence of two lymphoma susceptibility loci on the same chromosome, which exert mutually opposite effects, i.e., the STS allele at D16Mit34 confers resistance, while the STS allele at another locus confers sensitivity. Because the CcS-7/Dem strain contains an STS-derived segment distal to chromosome 16, we also examined the parental mice for the cross with the marker D16Mit5 in the distal segment. Indeed, some, but not all, of the mice retained the STS-derived segment. We then tested the cross with D16Mit5. The survival rate was 27% (13/48), 20% (12/59) and 8% (1/13), for the BALB/c homozygous, BALB/c and STS heterozygous, and STS homozygous genotypes, respectively, at this locus. Thus, the decrease in the survivorship was according to an increase in the number of STS alleles. This suggests the presence of another susceptibility locus near to D16Mit5, where the STS allele conversely confers sensitivity, though the linkage was insignificant (χ 2 =4.14, degrees of freedom = 2, P = 0.126, Log-Rank test). Thus, the STS allele at D16Mit34 might represent resistance; nevertheless, co-existence of the sensitive STS allele at another locus near to D16Mit5 with the STS allele at D16Mit34 could change the phenotype to the sensitive one. Because the two putative susceptibility loci exist on the same chromosome, the mice homozygous for the STS allele at D16Mit34 had a greater chance of carrying the sensitive STS allele(s) at another susceptibility locus near to D16Mit5 than the heterozygotes. Hence, the mice homozygous for the STS allele at D16Mit34 might have a sensitive phenotype. To validate this possibility, further study is necessary. The present study showed the existence of a locus responsible for susceptibility to radiation lymphomagenesis in the vicinity of D16Mit34 on chromosome 16. Because STS mice are highly resistant to radiation lymphomagenesis (4) , it is suspected that there exist other loci contributing to the resistance. Cancer risk after exposure to radiation and its biological basis have been studied in mice 13) as well as humans 14) . By shedding light upon the genetic basis of susceptibility to radiation lymphomagenesis in mice, it is hoped that our study will facilitate a cancer-risk estimation based on a propensity for carcinogenesis in humans exposed to radiation.
